Please Wait
Applying Filters...
menu
    • menu
    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-08-11

    Virtual Booth

    An Enquiry

    Menu

    Urcosimod

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OKYO Pharma's Phase 2 Results for Urcosimod in Corneal Pain
    OKYO Pharma's Phase 2 Results for Urcosimod in Corneal Pain

    16 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/16/3116513/0/en/OKYO-Pharma-Unveils-Strong-Phase-2-Clinical-Trial-Results-for-Urcosimod-to-Treat-Neuropathic-Corneal-Pain.html

    GLOBENEWSWIRE
    16 Jul 2025
    Share Share
    FDA Grants OKYO Fast Track for Urcosimod Neuropathic Corneal Pain
    FDA Grants OKYO Fast Track for Urcosimod Neuropathic Corneal Pain

    01 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/01/3072233/0/en/FDA-Grants-OKYO-Pharma-Fast-Track-Designation-to-Urcosimod-for-Neuropathic-Corneal-Pain.html

    GLOBENEWSWIRE
    01 May 2025
    Share Share